Stocks  /  NASDAQ  /  Bicara Therapeutics Inc.

Bicara Therapeutics Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   BCAXNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Bicara Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in the following report that they exploit animals for product testing.

“For both tests, a p-value of 0.05 or less is considered significant. In the relapse phase of the study, 6 animals relapsed in the cetuximab group as compared to 1 animal in the ficerafusp alfa group.” (Page 115) Read the full document

Company Description

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Company Website: https://www.bicara.com

Contact:  info@bicara.com
Scroll to Top